Sage Therapeutics has agreed to be acquired by Supernus Pharma in a deal valued at around $571 million, bringing together two companies working on central nervous system therapies that have ...

See the latest Sage Potash Corp Ordinary Shares stock price (SAGE:XTSX), related news, valuation, dividends and more to help you make your investing decisions.